Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Woman with diabetes had hair loss due to rare ovarian tumor; surgery improved hair growth.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Diane 35 plus finasteride is more effective for treating hirsutism.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Using finasteride with TIP extends time off period for prostate cancer patients.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

PCOS is a common hormonal disorder in women that can lead to various health issues and requires comprehensive management.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Treating PCOS is complex, involving medication like metformin and lifestyle changes, and requires attention to mental health due to high depression and anxiety rates.